B. Autran

B. Autran, N. Tarantino, S. Burrel, 2021, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Immunogenicity of BNT162b2 vaccine booster against SARS-CoV-2 Delta and Omicron variants in nursing home residents: A prospective observational study in older adults aged from 68 to 98 years

B. Autran, Y. Yazdanpanah, A. Duhamel, 2022, The Lancet Regional Health - Europe.

Control of vaccinia virus skin lesions by long-term-maintained IFN-γ+TNF-α+ effector/memory CD4+ lymphocytes in humans

B. Autran, F. Gay, B. Combadière, 2021 .

Control of vaccinia virus skin lesions by long-term-maintained IFN-gamma+TNF-alpha+ effector/memory CD4+ lymphocytes in humans.

B. Autran, F. Gay, B. Combadière, 2010, The Journal of clinical investigation.

Barriers to a cure for HIV: new ways to target and eradicate HIV-1 reservoirs

D. Richman, J. Martinez-Picado, C. Katlama, 2013, The Lancet.

This information is current as Response Alphavirus in Spite of a Robust Host Immune Infection by Chikungunya Arthritogenic Persistent Chronic Inflammation and

B. Autran, P. Debré, T. Henni, 2010 .

Immunogenicity and safety of yellow fever vaccine in HIV-1-infected patients

A. Samri, B. Autran, O. Launay, 2018, AIDS.

Characterization of pandemic influenza immune memory signature after vaccination or infection.

A. Samri, B. Autran, F. Carrat, 2014, The Journal of clinical investigation.

Pulmonary infections associated with systemic capillary leak syndrome attacks in a patient with hypogammaglobulinemia

T. Similowski, É. Oksenhendler, B. Autran, 1998, Intensive Care Medicine.

The SCID mouse mutant: definition and potential use as a model for immune and hematological disorders.

B. Autran, J. Cesbron, V. Leblond, 1997, Hematology and cell therapy.

Differential requirement of caspases during naive T cell proliferation

B. Autran, P. Debré, A. Boissonnas, 2002, European journal of immunology.

Compartment T Cell δγ Cytomegalovirus Infection on the Differential Impact of Age and Appay

B. Autran, V. Appay, A. Marchant, 2013 .

Neutrophils in antiretroviral therapy-controlled HIV demonstrate hyperactivation associated with a specific IL-17/IL-22 environment.

G. Carcelain, R. Tubiana, B. Autran, 2014, The Journal of allergy and clinical immunology.

reveals evidence of in vivo activation in a subset of organ donors Investigation of human spleen dendritic cell phenotype and distribution

A. Samri, B. Autran, A. Hosmalin, 2013 .

T lymphocyte subsets in primary antiphospholipid syndrome.

B. Autran, J. Piette, P. Godeau, 1994, The Journal of rheumatology.

No evidence for abnormal immune activation in peripheral blood T cells in patients with hepatitis C virus (HCV) infection with or without cryoglobulinaemia

B. Autran, L. Musset, P. Cacoub, 1998, Clinical and experimental immunology.

A T chronic lymphocytic leukemia with large granular lymphocytes phenotype and functions of leukemic cells under in vitro treatment by differentiation inducers

B. Autran, P. Debré, A. Vazquez, 1987, Cancer.

Antigen sensitivity is a major determinant of CD8+ T-cell polyfunctionality and HIV-suppressive activity.

B. Autran, V. Appay, L. Papagno, 2009, Blood.

Peripheral Blood Lymphocytes and Skin with HIVgp160 in SCID-hu Mice Coengrafted Primary Th1 Cell Immunization Against

B. Autran, J. Cesbron, N. Delhem, 1998 .

Safety and immunogenicity of a recombinant HIV type 1 glycoprotein 160 boosted by a V3 synthetic peptide in HIV-negative volunteers.

B. Autran, M. Kieny, J. Excler, 1995, AIDS research and human retroviruses.

Residual immune activation in combined antiretroviral therapy-treated patients with maximally suppressed viremia

V. Calvez, G. Carcelain, C. Katlama, 2016, AIDS.

Determinants of a Low CD4/CD8 Ratio in HIV-1-Infected Individuals Despite Long-term Viral Suppression.

V. Calvez, G. Carcelain, R. Tubiana, 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

PD-1 blockade in HIV-infected patients with lung cancer: a new challenge or already a strategy?

B. Autran, J. Spano, O. Lambotte, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

Transient HIV-specific T cells increase and inflammation in an HIV-infected patient treated with nivolumab.

A. Samri, B. Autran, J. Spano, 2017, AIDS.

HIV disease progression despite suppression of viral replication is associated with exhaustion of lymphopoiesis.

G. Carcelain, C. Katlama, B. Autran, 2011, Blood.

Blimp-1 overexpression is associated with low HIV-1 reservoir and transcription levels in central memory CD4+ T cells from elite controllers

B. Autran, C. Rouzioux, A. Kirilovsky, 2014, AIDS.

Explosion of tuberculin-specific Th1-responses induces immune restoration syndrome in tuberculosis and HIV co-infected patients

E. Vicaut, G. Carcelain, B. Autran, 2006, AIDS.

Human immunodeficiency virus-related lymphocytic alveolitis.

B. Autran, M. Denis, P. Fouret, 1988, Chest.

HCV cure: an appropriate moment to reduce cannabis use in people living with HIV? (ANRS CO13 HEPAVIH data)

M. Ziol, C. Delaugerre, C. Katlama, 2022, AIDS Research and Therapy.

Reduced Oxidative Burst by Primed Neutrophils in the Elderly Individuals Is Associated With Increased Levels of the CD16bright/CD62Ldim Immunosuppressive Subset

B. Autran, V. Appay, D. Sauce, 2017, The journals of gerontology. Series A, Biological sciences and medical sciences.

Oligoclonal expansion of CD8+ CD57+ T cells with restricted T-cell receptor beta chain variability after bone marrow transplantation.

F. Sigaux, B. Autran, P. Debré, 1994, Blood.

Limited HIV-2 reservoirs in central-memory CD4 T-cells associated to CXCR6 co-receptor expression in attenuated HIV-2 infection

C. Charpentier, F. Brun-Vézinet, A. Samri, 2019, PLoS pathogens.

Production in Women a Cell Levels of IRF5 Drive Higher IFN-Sex Differences in Plasmacytoid Dendritic

M. Altfeld, A. Villani, B. Autran, 2015 .

Dose-dependent systemic human immunodeficiency virus infection of SCID-hu mice after intraperitoneal virus injection.

H. Agut, B. Autran, P. Debré, 1995, Research in virology.

[Cytotoxic T cells against HIV].

B. Autran, P. Debré, 1990, Presse medicale.

The V1V2 Domain and an N-Linked Glycosylation Site in the V3 Loop of the HIV-1 Envelope Glycoprotein Modulate Neutralization Sensitivity to the Human Broadly Neutralizing Antibody 2G12

B. Autran, A. Moreau, A. Chaillon, 2011, Journal of Virology.

Demographic and Clinical Factors Associated with Response to Smallpox Vaccine in Preimmunized Volunteers

B. Autran, F. Gay, B. Lebrun-Vignes, 2008, PloS one.

Monoclonal B-cell response to diphtheria toxoid: evidence for cross-reactive epitopes.

B. Autran, P. Debré, M. Jolivet, 1987, Immunology.

An inhibitor of cytotoxic functions produced by CD8+CD57+ T lymphocytes from patients suffering from AIDS and immunosuppressed bone marrow recipients

B. Autran, L. Mollet, P. Debré, 1994, European journal of immunology.

Acquired constitutive expression of interferon beta after gene transduction enhances human immunodeficiency virus type 1-specific cytotoxic T lymphocyte activity by a RANTES-dependent mechanism.

B. Autran, P. Debré, I. Cremer, 1999, Human gene therapy.

Gene Rearrangement Analysis of Bronchoalveolar Lymphocytes by Polymerase Chain Reaction

B. Autran, J. Farcet, J. Clauvel, 2015 .

B-cell pulmonary lymphoma: gene rearrangement analysis of bronchoalveolar lymphocytes by polymerase chain reaction.

B. Autran, J. Farcet, J. Clauvel, 1999, Chest.

Multicentric Castleman's disease in HIV infection: a clinical and pathological study of 20 patients

J. Soulier, É. Oksenhendler, B. Autran, 1996, AIDS.

Influence of the ARV regimen on the early changes in plasma HIV RNA and immune activation at initiation of antiretroviral therapy in naïve HIV-1-infected patients.

B. Clotet, A. Samri, C. Katlama, 2020, Journal of acquired immune deficiency syndromes.

Up‐regulation of adhesion and MHC molecules on splenic monocyte/macrophages in adult haemophagocytic syndrome

É. Oksenhendler, A. Samri, B. Autran, 1999, British journal of haematology.

Antigen‐specific proliferative human T cell clones with specificity for diphtheria toxoid: genetic and molecular restriction by class II antigens

B. Autran, P. Debré, D. Charron, 1984, European journal of immunology.

HIV-1 and SIV Predominantly Use CCR5 Expressed on a Precursor Population to Establish Infection in T Follicular Helper Cells

B. Autran, D. Cooper, S. Alcântara, 2017, Front. Immunol..

AIDS IN A HAITIAN WOMAN WITH CARDIAC KAPOSI'S SARCOMA AND WHIPPLE'S DISEASE

B. Autran, I. Gorin, J. Hewitt, 1983, The Lancet.

Switch to maraviroc/raltegravir dual therapy leads to an unfavorable immune profile with low-level HIV viremia

C. Katlama, B. Autran, D. Costagliola, 2015, AIDS (London).

Identification of Autoreactive Human Bone Marrow and Peripheral Blood CD3−, CD4−, CD8−Prothymocytes

B. Autran, P. Debré, G. Gorochov, 1989 .

Expansion of Human Cytomegalovirus (HCMV) Immediate-Early 1-Specific CD8+ T Cells and Control of HCMV Replication after Allogeneic Stem Cell Transplantation

G. Carcelain, B. Autran, V. Leblond, 2008, Journal of Virology.

Expansion of Human Cytomegalovirus (HCMV) Immediate-Early 1-Speciﬁc CD8 (cid:1) T Cells and Control of HCMV Replication after Allogeneic Stem Cell Transplantation (cid:1)

G. Carcelain, B. Autran, V. Leblond, 2008 .

Barriers to a Cure: New concepts in targeting and eradicating HIV-1 reservoirs

Jeffrey, D. Richman, J. Martinez-Picado, 2013 .

Reply to Spellberg

B. Autran, C. Rouzioux, Nicole N’Go-Giang-Huong, 2006 .

iNKT and memory B-cell alterations in HHV-8 multicentric Castleman disease.

É. Oksenhendler, G. Carcelain, B. Autran, 2017, Blood.

In vivo role of IL-6 on the viral load and on immunological abnormalities of HIV-infected patients.

B. Autran, J. Aubin, H. Agut, 1996, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

Maraviroc-induced decrease in circulating bacterial products is not linked to an increase in immune activation in HIV-infected individuals.

B. Autran, L. Cuzin, J. Lavigne, 2013, Blood.

A novel mode of human immunodeficiency virus type 1 (HIV-1) activation: ligation of CD28 alone induces HIV-1 replication in naturally infected lymphocytes

B. Autran, P. Debré, Y. Dudoit, 1993 .

Alveolar CD8+CD57+ lymphocytes in human immunodeficiency virus infection produce an inhibitor of cytotoxic functions.

B. Autran, P. Debré, A. Parrot, 1994, American journal of respiratory and critical care medicine.

Expansion of CD4+CD7- T cells, a memory subset with preferential interleukin-4 production, after bone marrow transplantation.

B. Autran, P. Debré, V. Leblond, 1997, Transplantation.

Impact of Anti PD-1 Immunotherapy on HIV Reservoir and Anti-Viral Immune Responses in People Living with HIV and Cancer

A. Samri, C. Katlama, B. Autran, 2022, Cells.

In vitro immunomodulation of human islet allografts using mixed islet lymphocyte coculture.

B. Autran, P. Debré, C. Suberbielle, 1997, Transplantation proceedings.

Identifying Cytomegalovirus Complications Using the Quantiferon-CMV Assay After Allogeneic Hematopoietic Stem Cell Transplantation

G. Carcelain, A. Samri, B. Autran, 2017, The Journal of infectious diseases.

Serum Tryptophan-Derived Quinolinate and Indole-3-Acetate Are Associated With Carotid Intima-Media Thickness and its Evolution in HIV-Infected Treated Adults

A. Samri, B. Autran, J. Capeau, 2019, Open forum infectious diseases.

Intratumoral activation of CD8-positive cytotoxic lymphocytes in acquired immunodeficiency syndrome lymphomas.

B. Autran, M. Raphael, P. Galanaud, 1995, Human pathology.

Bioterrorism: management of major biological agents.

B. Autran, P. Bossi, F. Bricaire, 2006, Cellular and molecular life sciences : CMLS.

Changes in T-cell subsets in HIV–HCV-coinfected patients during pegylated interferon-α2a plus ribavirin treatment

B. Clotet, C. Tural, B. Autran, 2010, Antiviral therapy.

A lectin‐binding soluble factor released by CD8+CD57+ lymphocytes from AIDS patients inhibits T cell cytotoxicity

C. Katlama, B. Autran, P. Debré, 1991, European journal of immunology.

Phenotype and function of peripheral blood and bone marrow T-cell colonies: identification of DC3-, 4-, 8-autoreactive T cells.

B. Autran, P. Debré, G. Gorochov, 1989, Human immunology.

Erratum: (Retracted article): Clinical course of cardiomyopathy in HIV-infected patients with or without encephalopathy related to the myocardial expression of tumour necrosis factor-α and nitric oxide synthase (AIDS (2002) 14 (827-838))

J. Phair, B. Autran, J. Levy, 2004 .

Reply to Immunometabolism may provide insights into novel mechanisms of HIV reservoir persistence.

C. Katlama, B. Autran, M. Pogliaghi, 2016, AIDS.

Immune checkpoint inhibitors in people living with HIV: what about anti-HIV effects?

C. Katlama, B. Autran, J. Spano, 2020, AIDS.

Retraction. Clinical course of cardiomyopathy in HIV-infected patients with or without encephalopathy related to the myocardial expression of tumour necrosis factor-alpha and nitric oxide synthase.

J. Phair, B. Autran, J. Levy, 2004, AIDS.

Antibodies raised against peptide fragments of CD16 reacting with membrane and soluble form of CD16. I: Production and characterization.

B. Autran, M. Weil, D. Khayat, 1992, Hybridoma.

A therapeutic dendritic cell-based vaccine for HIV-1 infection.

B. Clotet, J. Martinez-Picado, J. Romeu, 2011, The Journal of infectious diseases.

Oligoclonal Expansion of CD 8 + CD 57 + T Cells With Restricted T-cell Receptor / 3 Chain Variability After Bone Marrow Transplantation

F. Sigaux, B. Autran, P. Debré, 2002 .

Cell-mediated suppression of HIV-specific cytotoxic T lymphocytes.

B. Autran, P. Debré, M. Denis, 1989, Journal of immunology.

Effect of two injections of non-adjuvanted influenza A H1N1pdm2009 vaccine in renal transplant recipients: INSERM C09-32 TRANSFLUVAC trial.

B. Autran, E. Morelon, D. Bottigioli, 2012, Vaccine.

Effect of therapeutic intensification followed by HIV DNA prime and rAd5 boost vaccination on HIV-specific immunity and HIV reservoir (EraMune 02): a multicentre randomised clinical trial.

V. Calvez, C. Katlama, B. Autran, 2015, The lancet. HIV.

Low serum neutralization of Omicron variants a month after AZD7442 prophylaxis initiation

B. Autran, Y. Yazdanpanah, J. Gottenberg, 2022, Journal of Infection.

Studies of T cell reconstitution after hematopoietic stem cell transplant.

B. Autran, P. Debré, V. Leblond, 1997, Hematology and cell therapy.

Evidence for naive T-cell repopulation despite thymus irradiation after autologous transplantation in adults with multiple myeloma: role of ex vivo CD34+ selection and age.

G. Carcelain, B. Autran, P. Debré, 2003, Blood.

Direct Quantiﬁcation of Cell-Associated HIV DNA in Isolated Rectal and Blood Memory CD4 T Cells Revealed Their Similar and Low Infection Levels in Long-Term Treated HIV-Infected Patients

G. Carcelain, R. Tubiana, A. Samri, 2018 .

Direct Quantification of Cell-Associated HIV DNA in Isolated Rectal and Blood Memory CD4 T Cells Revealed Their Similar and Low Infection Levels in Long-Term Treated HIV-Infected Patients

G. Carcelain, R. Tubiana, A. Samri, 2013, Journal of acquired immune deficiency syndromes.

Drastic decrease of the HIV reservoir in a patient treated with nivolumab for lung cancer.

A. Samri, B. Autran, J. Spano, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

Hepatitis C virus infection in long-term nonprogressor HIV-1-infected subjects.

H. Agut, B. Autran, A. Cahour, 2002, Journal of acquired immune deficiency syndromes.

Management of Multidrug-Resistant CMV Infection in Immunocompromised Patients: Case Report of a Heart-Transplant Recipient and Review of the Literature

G. Carcelain, H. Agut, B. Autran, 2015, Antiviral therapy.

Rapid progression to AIDS in HIV+ individuals with a structural variant of the chemokine receptor CX3CR1.

E. Génin, B. Autran, P. Debré, 2000, Science.

Evidence for a cytotoxic T-lymphocyte alveolitis in human immunodeficiency virus-infected patients.

B. Autran, P. Debré, M. Denis, 1988, AIDS.

CD8hi+CD57+ T lymphocytes are enriched in antigen-specific T cells capable of down-modulating cytotoxic activity.

V. Calvez, C. Katlama, B. Autran, 1998, International immunology.

Multicentric Castleman disease is associated with polyfunctional effector memory HHV-8-specific CD8+ T cells.

É. Oksenhendler, G. Carcelain, B. Autran, 2008, Blood.

Immune reconstitution after highly active anti-retroviral treatment of HIV infection.

G. Carcelain, B. Autran, P. Debré, 2001, Advances in experimental medicine and biology.

CMV driven CD8(+) T-cell activation is associated with acute rejection in lung transplantation.

B. Autran, V. Appay, D. Douek, 2013, Clinical immunology.

A Dendritic Cell–Based Vaccine Elicits T Cell Responses Associated with Control of HIV-1 Replication

B. Clotet, J. Martinez-Picado, B. Autran, 2013, Science Translational Medicine.

Transfer of Human CD4+ T Lymphocytes Producing Beta Interferon in Hu-PBL-SCID Mice Controls Human Immunodeficiency Virus Infection

B. Autran, P. Debré, V. Vieillard, 1999, Journal of Virology.

Defective p56Lck activity in T cells from an adult patient with idiopathic CD4+ lymphocytopenia.

M Seligmann, É. Oksenhendler, B. Autran, 2000, International immunology.

Idiopathic CD4 Lymphocytopenia

É. Oksenhendler, G. Carcelain, B. Autran, 2014, Medicine.

Idiopathic CD4 Lymphocytopenia

É. Oksenhendler, G. Carcelain, B. Autran, 2014, Medicine.

Multiple subsets of HIV‐specific cytotoxic T lymphocytes in humans and in mice

B. Guy, B. Autran, M. Kieny, 1989, European journal of immunology.

AIDS virus-specific cytotoxic T lymphocytes in lung disorders

B. Autran, P. Debré, S. Wain-Hobson, 1987, Nature.

Immune recognition of AIDS virus antigens by human and murine cytotoxic T lymphocytes.

B. Autran, S. Wain-Hobson, G. Dadaglio, 1988, Journal of immunology.

Human trophoblast cells express CD4 and are permissive for productive infection with HIV‐1

B. Autran, P. Debré, F. Barré-Sinoussi, 1992, Clinical and experimental immunology.

Reactivity of lymphocytes to a progesterone receptor-specific monoclonal antibody.

B. Autran, P. Debré, G. Chaouat, 1990, Cellular immunology.

Immunoregulatory effects of a suppressor factor from healthy pregnant women's lymphocytes after progesterone induction.

B. Autran, P. Debré, G. Chaouat, 1989, Cellular immunology.

Persistent Chronic Inflammation and Infection by Chikungunya Arthritogenic Alphavirus in Spite of a Robust Host Immune Response

B. Autran, P. Debré, T. Henni, 2010, The Journal of Immunology.

Impact of therapeutic immunization on HIV-1 viremia after discontinuation of antiretroviral therapy initiated during acute infection.

B. Autran, M. Battegay, L. Perrin, 2005, Journal of Infectious Diseases.

Vaccination in HIV-infected individuals

B. Autran, N. Corre, 2012 .

PD-1 expression on human CD8 T cells depends on both state of differentiation and activation status

G. Freeman, B. Autran, V. Appay, 2007, AIDS.

HIV

S. Seedat, C. Katlama, B. Autran, 2018, The Lancet.

Towards an HBV cure: state-of-the-art and unresolved questions—report of the ANRS workshop on HBV cure

B. Autran, F. Carrat, F. Zoulim, 2015, Gut.

Influence of antigen exposure on the loss of long-term memory to childhood vaccines in HIV-infected patients.

C. Katlama, B. Autran, D. Duffy, 2009, Vaccine.

T cell changes after combined nucleoside analogue therapy in HIV primary infection.

G. Carcelain, B. Autran, P. Debré, 1999, AIDS.

Therapeutic Vaccines for Chronic Infections

G. Carcelain, B. Autran, P. Debré, 2004, Science.

Anticardiolipin antibodies in HIV infection are independently associated with antibodies to the membrane proximal external region of gp41 and with cell-associated HIV DNA and immune activation.

B. Autran, D. Costagliola, L. Musset, 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

A patient with HIV-1 superinfection.

A. Samri, B. Autran, S. Yerly, 2002, The New England journal of medicine.

Evaluating therapeutic vaccines in patients infected with HIV

C. Katlama, B. Autran, D. Costagliola, 2004, Expert review of vaccines.

Determinants of paradoxical CD4 cell reconstitution after protease inhibitor-containing antiretroviral regimen.

V. Calvez, G. Carcelain, R. Tubiana, 1999, AIDS.

Long-lasting recovery in CD4 T-cell function and viral-load reduction after highly active antiretroviral therapy in advanced HIV-1 disease

V. Calvez, R. Tubiana, C. Katlama, 1998, The Lancet.

Immune reconstitution after a decade of combined antiretroviral therapies for human immunodeficiency virus.

G. Carcelain, B. Autran, A. Guihot, 2011, Trends in immunology.

Superior control of HIV-1 replication by CD8+ T cells is reflected by their avidity, polyfunctionality, and clonal turnover

David A. Price, Brigitte Autran, Assia Samri, 2007, The Journal of experimental medicine.

International AIDS Society global scientific strategy: towards an HIV cure 2016

Richard Jefferys, David Margolis, Jintanat Ananworanich, 2016, Nature Medicine.

Long-term nonprogressors and elite controllers in the ANRS CO5 HIV-2 cohort

F. Brun-Vézinet, B. Autran, R. Thiébaut, 2011, AIDS.

Discontinuation of maintenance therapy for cytomegalovirus retinitis in HIV-infected patients receiving highly active antiretroviral therapy

C. Tural, G. Carcelain, R. Tubiana, 2001, AIDS.

Immune response to diphtheria toxin and to different CNBr fragments: Evidence for different B and T cell reactivities

B. Autran, P. Debré, Frédéric Triebel, 1986, European journal of immunology.

L. Quéro, G. Carcelain, C. Katlama, 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

Good response to lopinavir/ritonavir-containing antiretroviral regimens in antiretroviral-naive HIV-2-infected patients

F. Brun-Vézinet, B. Autran, G. Peytavin, 2009, AIDS.

Low T cell responses to human herpesvirus 8 in patients with AIDS-related and classic Kaposi sarcoma.

É. Oksenhendler, G. Carcelain, B. Autran, 2006, The Journal of infectious diseases.

Comprehensive Mass Cytometry Analysis of Cell Cycle, Activation, and Coinhibitory Receptors Expression in CD4 T Cells from Healthy and HIV‐Infected Individuals

C. Katlama, B. Autran, C. Blanc, 2017, Cytometry. Part B, Clinical cytometry.

The Th1 immune response against HIV‐1 Gag p24‐derived peptides in mice expressing HLA‐A02.01 and HLA‐DR1

B. Autran, A. Pajot, F. Lemonnier, 2007, European journal of immunology.

Separation of Mononuclear Bone Marrow Cells using the Cobe 2997 Blood Cell Separator

B. Autran, J. Bergerat, J. Binet, 1988, Vox sanguinis.

Single DermaVir Immunization: Dose-Dependent Expansion of Precursor/Memory T Cells against All HIV Antigens in HIV-1 Infected Individuals

J. Lisziewicz, F. Lori, B. Autran, 2012, PloS one.

Felipe García Control of HIV-1 Replication Based Vaccine Elicits T Cell Responses Associated with − A Dendritic Cell

Felipe García, Brigitte Autran, Agathe León, 2012 .

Immune interventions in HIV infection

G. Carcelain, B. Autran, 2013, Immunological reviews.

Effect of lentivirus encoding HIV-1 Nef-U3 shRNA on the function of HIV-specific memory CD4+ T cells in patients with chronic HIV-1 infection

A. Samri, B. Autran, Y. Tsunetsugu-Yokota, 2009, AIDS.

A soluble factor released by CD8+CD57+ lymphocytes from bone marrow transplanted patients inhibits cell-mediated cytolysis.

B. Autran, P. Debré, J. Binet, 1991, Blood.

Primary Th1 cell immunization against HIVgp160 in SCID-hu mice coengrafted with peripheral blood lymphocytes and skin.

B. Autran, J. Cesbron, N. Delhem, 1998, Journal of immunology.

rIL 2-induced proliferation of human circulating NK cells and T lymphocytes: synergistic effects of IL 1 and IL 2.

B. Autran, O. Lantz, B. Charpentier, 1987, Journal of immunology.

Differentiation associated regulation of microRNA expression in vivo in human CD8+ T cell subsets

Pedro Romero, Brigitte Autran, Victor Appay, 2011, Journal of Translational Medicine.

HIV and T cell expansion in splenic white pulps is accompanied by infiltration of HIV-specific cytotoxic T lymphocytes

É. Oksenhendler, B. Autran, R. Cheynier, 1994, Cell.

IL-2 therapy and thymic production of naive CD4 T cells in HIV-infected patients with severe CD4 lymphopenia

Brigitte Autran, Roland Tubiana, Christine Katlama, 2003, AIDS.

Carboxyl-terminal and central regions of human immunodeficiency virus-1 NEF recognized by cytotoxic T lymphocytes from lymphoid organs. An in vitro limiting dilution analysis.

B. Autran, P. Debré, M. Kieny, 1992, The Journal of clinical investigation.

Cell-Mediated Immune Responses to COVID-19 Infection

B. Autran, P. Debré, V. Vieillard, 2020, Frontiers in Immunology.

Towards an HIV cure: a global scientific strategy

M. Lederman, J. Mullins, A. Telenti, 2012, Nature Reviews Immunology.

Old age and anti-cytomegalovirus immunity are associated with altered T-cell reconstitution in HIV-1-infected patients

C. Katlama, B. Autran, V. Appay, 2011, AIDS.

Consistency of routine measurements of CD4+, CD8+ peripheral blood lymphocytes.

B. Autran, P. Debré, K. Beldjord, 1992, Journal of immunological methods.

Minocycline-induced Cell-mediated Hypersensitivity Pneumonitis

B. Autran, P. Debré, M. Denis, 1992, Annals of Internal Medicine.

Imbalanced "memory" T lymphocyte subsets and analysis of dendritic cell precursors in the peripheral blood of adult patients with Langerhans cell histiocytosis.

B. Autran, P. Debré, S. Herson, 1997, Clinical and experimental rheumatology.

SARS-CoV-2 variants and ending the COVID-19 pandemic

B. Autran, M. Kieny, S. Karim, 2021, The Lancet.

Disease progression due to dual infection in an HLA-B57-positive asymptomatic long-term nonprogressor infected with a nef-defective HIV-1 strain.

A. Samri, H. Agut, B. Autran, 2010, Virology.

Combination of HIV-1-specific CD4 Th1 cell responses and IgG2 antibodies is the best predictor for persistence of long-term nonprogression.

H. Agut, B. Autran, P. Debré, 2005, The Journal of infectious diseases.

HIV-1 therapeutic vaccines.

B. Autran, S. Kinloch-de Loes, 2002, The Journal of infection.

HIV-specific effector cytotoxic T lymphocytes and HIV-producing cells colocalize in white pulps and germinal centers from infected patients.

É. Oksenhendler, A. Samri, B. Autran, 2001, Blood.

Status of long‐term asymptomatic HIV‐1 infection correlates with viral load but not with virus replication properties and cell tropism

H. Agut, B. Autran, C. Rouzioux, 1999, Journal of medical virology.

Perturbation of CD4+ and CD8+ T-cell repertoires during progression to AIDS and regulation of the CD4+ repertoire during antiviral therapy

C. Katlama, B. Autran, A. Neumann, 1998, Nature Medicine.

Leukemic CD3+ LGL share functional properties with their CD8+CD57+ cell counterpart expanded after BMT

B. Autran, L. Mollet, P. Debré, 1999, Leukemia.

CD8 lymphocytosis and pseudotumoral splenomegaly in HIV infection

É. Oksenhendler, B. Autran, J. Clauvel, 1992, The Lancet.

The link between CD8+ T-cell antigen-sensitivity and HIV-suppressive capacity depends on HLA restriction, target epitope and viral isolate

B. Autran, V. Appay, L. Papagno, 2014, AIDS.

Correlation between breadth of memory HIV-specific cytotoxic T cells, viral load and disease progression in HIV infection

V. Calvez, C. Katlama, B. Autran, 2002, AIDS.

Distinct differentiation profiles of HIV-Gag and Nef-specific central memory CD8+ T cells associated with HLA-B57/5801 and virus control

W. Lu, A. Samri, B. Autran, 2010, AIDS.

Destructive arthritis in a patient with chikungunya virus infection with persistent specific IgM antibodies

B. Autran, K. Ezzedine, D. Malvy, 2009, BMC infectious diseases.

CTL Escape Mediated by Proteasomal Destruction of an HIV-1 Cryptic Epitope

P. Kloetzel, P. van Endert, C. Katlama, 2011, PLoS pathogens.

Dynamics of viral variants in HIV-1 Nef and specific cytotoxic T lymphocytes in vivo.

C. Katlama, B. Autran, P. Debré, 1996, Journal of immunology.

Combined ART started during acute HIV infection protects central memory CD4+ T cells and can induce remission.

A. Samri, B. Autran, C. Rouzioux, 2015, The Journal of antimicrobial chemotherapy.

A Single HIV-1 Cluster and a Skewed Immune Homeostasis Drive the Early Spread of HIV among Resting CD4+ Cell Subsets within One Month Post-Infection

C. Katlama, B. Autran, Y. Yazdanpanah, 2013, PloS one.

Immune responses driven by protective human leukocyte antigen alleles from long-term nonprogressors are associated with low HIV reservoir in central memory CD4 T cells.

G. Carcelain, A. Samri, B. Autran, 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Identical Strength of the T Cell Responses against E2, nsP1 and Capsid CHIKV Proteins in Recovered and Chronic Patients after the Epidemics of 2005-2006 in La Reunion Island

A. Samri, B. Autran, P. Gasque, 2013, PloS one.

PersistentChronic Inflammation and Infection byChikungunya Arthritogenic Alphavirus in Spite of a Robust Host Immune Response

B. Autran, P. Debré, T. Henni, 2010 .

Accelerated immune senescence and HIV-1 infection

B. Autran, V. Appay, L. Papagno, 2007, Experimental Gerontology.

Immunogenicity of Mutations Induced by Nucleoside Reverse Transcriptase Inhibitors for Human Immunodeficiency Virus Type 1-Specific Cytotoxic T Cells

V. Calvez, A. Samri, C. Katlama, 2000, Journal of Virology.

Cytotoxic T Lymphocytes in HIV-1 Infection

B. Autran, M. Klein, S. H. Burg, 2000 .

Dynamics of HIV variants and specific cytotoxic T-cell recognition in nonprogressors and progressors.

B. Autran, P. Debré, F. Hadida, 1997, Immunology letters.

Unusually high frequencies of HIV-specific cytotoxic T lymphocytes in humans.

B. Autran, G. Dadaglio, P. Langlade‐Demoyen, 1989, Journal of immunology.

Single-nucleotide polymorphism-defined class I and class III major histocompatibility complex genetic subregions contribute to natural long-term nonprogression in HIV infection.

B. Autran, P. Debré, F. Macciardi, 2012, The Journal of infectious diseases.

HIV-Specific B Cell Frequency Correlates with Neutralization Breadth in Patients Naturally Controlling HIV-Infection

N. Paul, A. Samri, B. Autran, 2017, EBioMedicine.

Escape from highly effective public CD8+ T-cell clonotypes by HIV.

Brigitte Autran, Christian Brander, Victor Appay, 2011, Blood.

Post-Treatment HIV-1 Controllers with a Long-Term Virological Remission after the Interruption of Early Initiated Antiretroviral Therapy ANRS VISCONTI Study

Brigitte Autran, Laurence Meyer, Asier Sáez-Cirión, 2013, PLoS pathogens.

Treatment interruption in chronically HIV-infected patients with an ultralow HIV reservoir

V. Calvez, G. Carcelain, R. Tubiana, 2016, AIDS.

Treatment intensification followed by interleukin-7 reactivates HIV without reducing total HIV DNA: a randomized trial

V. Calvez, B. Clotet, C. Katlama, 2016, AIDS.

Immune Reconstitution of the CD4 T‐Cell Compartment in HIV Infection

G. Carcelain, B. Autran, P. Debré, 2001 .

T cell receptor gamma/delta+ lymphocyte subsets during HIV infection.

C. Katlama, B. Autran, P. Debré, 1989, Clinical and experimental immunology.

Clonal expansion of T cells and HIV genotypes in microdissected splenic white pulps indicates viral replication in situ and infiltration of HIV-specific cytotoxic T lymphocytes.

É. Oksenhendler, B. Autran, R. Cheynier, 1995, Advances in experimental medicine and biology.

NYVAC immunization induces polyfunctional HIV‐specific T‐cell responses in chronically‐infected, ART‐treated HIV patients

B. Autran, G. Pantaleo, M. Cavassini, 2012, European journal of immunology.

Initiating Antiretroviral Treatment Early in Infancy Has Long-term Benefits on the Human Immunodeficiency Virus Reservoir in Late Childhood and Adolescence.

A. Samri, B. Autran, P. Frange, 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

A systematic comparison of methods to measure HIV-1 specific CD8 T cells.

G. Carcelain, A. Samri, B. Autran, 2003, Journal of immunological methods.

Low-Coverage Whole Genome Sequencing of Cell-Free DNA From Immunosuppressed Cancer Patients Enables Tumor Fraction Determination and Reveals Relevant Copy Number Alterations

M. Sanson, B. Autran, P. Böelle, 2021, Frontiers in Cell and Developmental Biology.

Distinct Time Effects of Vaccination on Long-Term Proliferative and IFN-γ–producing T Cell Memory to Smallpox in Humans

G. Carcelain, A. Samri, B. Autran, 2004, The Journal of experimental medicine.

Reconstitution of CD4+ T lymphocytes in HIV-infected individuals following antiretroviral therapy.

G. Carcelain, B. Autran, P. Debré, 2001, Current opinion in immunology.

Factors associated with a low HIV reservoir in patients with prolonged suppressive antiretroviral therapy.

V. Calvez, G. Carcelain, R. Tubiana, 2014, The Journal of antimicrobial chemotherapy.

T-cell subset counting and the fight against AIDS: reflections over a 20-year struggle.

B. Autran, G. Janossy, F. Mandy, 2002, Cytometry.

Elite controllers as a model of functional cure

B. Autran, C. Rouzioux, B. Descours, 2011, Current opinion in HIV and AIDS.

Polymorphism in the proximal promoter region of the perforin gene and its impact on the course of HIV infection

A. Samri, B. Autran, P. Debré, 2006, International journal of immunogenetics.

Increased mortality in HIV/HCV-coinfected compared to HCV-monoinfected patients in the DAA era due to non-liver-related death.

V. de Lédinghen, V. Paradis, B. Autran, 2020, Journal of hepatology.

CD4+Ki67+ lymphocytes in HIV‐infected patients are effector T cells accumulated in the G1 phase of the cell cycle

V. Calvez, G. Carcelain, R. Tubiana, 2000, European journal of immunology.

Cytotoxic T-Lymphocyte Responses to HIV

B. Autran, 1996 .

HIV-specific cytotoxic T lymphocytes against alveolar macrophages: specificities and downregulation.

B. Autran, P. Debré, F. Hadida, 1991, Research in virology.

HIV-1 infection of lung alveolar fibroblasts and macrophages in humans.

B. Autran, F. Lebargy, A. Ryter, 1990, AIDS research and human retroviruses.

A simplified flow cytometry method of CD4 and CD8 cell counting based on thermoresistant reagents: Implications for large scale monitoring of HIV‐infected patients in resource‐limited settings

B. Autran, A. Lazzarin, V. Colizzi, 2005, Cytometry. Part B, Clinical cytometry.

Modulation of interleukin-7 receptor expression characterizes differentiation of CD8 T cells specific for HIV, EBV and CMV

Denis Puthier, Brigitte Autran, Christine Katlama, 2005, AIDS.

Decreased frequencies of virus-specific T helper type 1 cells during interferon alpha plus ribavirin treatment in HIV–hepatitis C virus co-infection

C. Katlama, B. Autran, T. Poynard, 2003, AIDS.

Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID-19 (Bari-SolidAct): a randomised, double-blind, placebo-controlled phase 3 trial

Inge Christoffer Olsen, F. Lund-Johansen, Mariana H. S. Bernardo, 2023, Critical Care.

No influence of human herpesvirus 8 infection on the progression of HIV‐1 infection in initially asymptomatic patients

V. Calvez, H. Agut, B. Autran, 2003, AIDS.

Lymphocytes with Changes in Viral Load T + Dynamics of HIV-Specific CD8

Brigitte Autran, Roland Tubiana, Vincent Calvez, 2014 .

Patient-reported symptoms during direct-acting antiviral treatment: A real-life study in HIV-HCV coinfected patients (ANRS CO13 HEPAVIH).

M. Ziol, V. Paradis, C. Delaugerre, 2020, Journal of hepatology.

HIV epitopes recognized by cytotoxic T-lymphocytes.

B. Autran, N. Letvin, 1991, AIDS.

Greater viral rebound and reduced time to resume antiretroviral therapy after therapeutic immunization with the ALVAC-HIV vaccine (vCP1452)

B. Walker, V. Calvez, B. Clotet, 2008, AIDS.

P16-17. Antigen sensitivity is a major determinant of CD8+ T-cell polyfunctionality and HIV suppressive activity

B. Autran, V. Appay, L. Papagno, 2009, Retrovirology.

Cytotoxic T‐cell responses to HIV‐1 reverse transcriptase, integrase and protease

A. Samri, C. Katlama, B. Autran, 1998, AIDS.

Evolution and plasticity of CTL responses against HIV.

B. Autran, F. Hadida, G. Haas, 1996, Current opinion in immunology.

HIV type 1-specific IgG2 antibodies: markers of helper T cell type 1 response and prognostic marker of long-term nonprogression.

H. Agut, B. Autran, C. Rouzioux, 2001, AIDS research and human retroviruses.

A triple-mutated allele of granzyme B incapable of inducing apoptosis

A. Samri, B. Autran, P. Debré, 2003, Proceedings of the National Academy of Sciences of the United States of America.

Dynamics of HIV-specific CD8+ T lymphocytes with changes in viral load.The RESTIM and COMET Study Groups.

V. Calvez, R. Tubiana, A. Samri, 2000, Journal of immunology.

What Is the most Important for Elite Control: Genetic Background of Patient, Genetic Background of Partner, both or neither? Description of Complete Natural History within a Couple of MSM

P. André, G. Carcelain, A. Samri, 2017, EBioMedicine.

One Step Closer to HIV Eradication?

C. Katlama, B. Autran, C. Hamimi, 2014, Current Treatment Options in Infectious Diseases.

Perspectives for immunotherapy: which applications might achieve an HIV functional cure?

C. Katlama, B. Autran, P. Debré, 2016, Oncotarget.

Cell permeabilization for the assessment of T lymphocyte polyfunctional capacity.

B. Autran, V. Appay, L. Papagno, 2007, Journal of immunological methods.

Low infection frequency of macrophages in the spleens of HIV+ patients.

É. Oksenhendler, B. Autran, P. Debré, 1996, Research in virology.

Low CD83, but normal MHC class II and costimulatory molecule expression, on spleen dendritic cells from HIV+ patients.

É. Oksenhendler, B. Autran, P. Debré, 1998, AIDS research and human retroviruses.

T Cells δγ and KIR-Negative Involves Tuberculin-Specific CD 4 Th 1 Cells Syndrome in HIV-1-Infected Patients Tuberculosis-Associated Immune Restoration Autran

E. Vicaut, G. Carcelain, A. Samri, 2009 .

Evaluation of the Interlaboratory Concordance in Quantification of Human Immunodeficiency Virus-Specific T Cells with a Gamma Interferon Enzyme-Linked Immunospot Assay

A. Samri, B. Autran, E. Tartour, 2006, Clinical and Vaccine Immunology.

CTLs from lymphoid organs recognize an optimal HLA-A2-restricted and HLA-B52-restricted nonapeptide and several epitopes in the C-terminal region of HIV-1 Nef.

A. Samri, B. Autran, P. Debré, 1995, Journal of immunology.

Registration of clinical trials.

J. Phair, B. Autran, J. Levy, 2005, AIDS.

HCV drives increased type I IFN-associated impairments associated to fibrosis severity in ART-treated HIV-1-HCV coinfected individuals.

M. Altfeld, C. Katlama, B. Autran, 2017, AIDS.

Safety and immunogenicity of a live recombinant canarypox virus expressing HIV type 1 gp120 MN tm/gag/protease LAI (ALVAC-HIV, vCP205) followed by a p24E-V3 MN synthetic peptide (CLTB-36) administered in healthy volunteers at low risk for HIV infection

B. Autran, J. Tartaglia, P. Chong, 1999 .

Analysis by flow cytometry of tyrosine-phosphorylated proteins in activated T-cell subsets on whole blood samples.

B. Autran, P. Debré, P. Hubert, 1997, Cytometry.

Repertoire, diversity, and differentiation of specific CD8 T cells are associated with immune protection against human cytomegalovirus disease

G. Carcelain, C. Katlama, B. Autran, 2005, The Journal of experimental medicine.

A truncated HIV Tat demonstrates potent and specific latency reversal activity

B. Autran, D. Margolis, N. Archin, 2023, bioRxiv.

Preservation of immune function and anti-hepatitis C virus (HCV) immune responses after liver transplantation in HIV-HCV coinfected patients (ANRS-HC08 "THEVIC" trial).

A. Samri, B. Autran, D. Samuel, 2009, Journal of hepatology.

T Cells Subtypes in a Patient With Interferon-&agr; Induced Sarcoidosis

G. Carcelain, B. Autran, J. Monsuez, 2009, The American journal of the medical sciences.

Restoration of the immune system with anti-retroviral therapy.

V. Calvez, C. Katlama, B. Autran, 1999, Immunology letters.

Markov modelling of changes in HIV‐specific cytotoxic T‐lymphocyte responses with time in untreated HIV‐1 infected patients

D Costagliola, V. Calvez, C. Katlama, 2003, Statistics in medicine.

Toward a cure for HIV—Seeking effective therapeutic vaccine strategies

B. Autran, 2015, European journal of immunology.

The chemokine receptor CX3CR1 controls homing and anti‐viral potencies of CD8 effector‐memory T lymphocytes in HIV‐infected patients

B. Autran, P. Debré, C. Combadière, 2003, AIDS.

Immunodeficiency in HIV infection and AIDS

B. Autran, G. Janossy, F. Miedema, 1992 .

Thymocyte and thymic microenvironment alterations during a systemic HIV infection in a severe combined immunodeficient mouse model

H. Agut, B. Autran, P. Debré, 1996, AIDS.

High-dose therapy and autologous haematopoietic stem-cell transplantation for HIV-1-associated lymphoma

C. Katlama, B. Autran, V. Leblond, 2000, The Lancet.

SCID-Hu mouse as a model for human lung HIV-1 infection.

H. Agut, B. Autran, P. Debré, 1994, Comptes rendus de l'Academie des sciences. Serie III, Sciences de la vie.

CD34+ selection and age autologous transplantation in adults with multiple myeloma: role of ex-vivo Evidence for naive T-cell repopulation despite thymus irradiation after

G. Carcelain, B. Autran, P. Debré, 2013 .

Factors influencing the efficacy of two injections of a pandemic 2009 influenza A (H1N1) nonadjuvanted vaccine in systemic lupus erythematosus.

B. Autran, J. Piette, L. Arnaud, 2011, Arthritis and rheumatism.

A prospective national cohort evaluating ring MVA vaccination as post-exposure prophylaxis for monkeypox

B. Autran, E. Tartour, T. Simon, 2022, Nature Medicine.

HIV therapeutic vaccine enhances non-exhausted CD4+ T cells in a randomised phase 2 trial

R. Tubiana, C. Katlama, B. Autran, 2019, npj Vaccines.

Three-Year Immune Reconstitution in PI-Sparing and PI-Containing Antiretroviral Regimens in Advanced HIV-1 Disease

A. Samri, B. Autran, G. Pantaleo, 2007, Antiviral therapy.

Increase of HIV-1 Pro-Viral Dna per Million Peripheral Blood Mononuclear Cells in Patients with Advanced HIV Disease (Cd4<200 Cells/Mm3) Receiving Interleukin 2 Combined with Haart Versus Haart Alone (Anrs-082 Trial)

M. Mouroux, V. Calvez, G. Carcelain, 2002, Antiviral therapy.

Cynomolgus macaque IL37 polymorphism and control of SIV infection

T. Shiina, B. Autran, N. Tchitchek, 2019, Scientific Reports.

Yeast-Derived Human Immunodeficiency Virus Type 1 p55gag Virus-Like Particles Activate Dendritic Cells (DCs) and Induce Perforin Expression in Gag-Specific CD8+ T Cells by Cross-Presentation of DCs

B. Autran, Tetsuya Nakamura, A. Iwamoto, 2003, Journal of Virology.

Tuberculosis-Associated Immune Restoration Syndrome in HIV-1-Infected Patients Involves Tuberculin-Specific CD4 Th1 Cells and KIR-Negative γδ T Cells1

E. Vicaut, G. Carcelain, A. Samri, 2009, The Journal of Immunology.

Serum neutralization of SARS-CoV-2 Omicron sublineages BA.1 and BA.2, and cellular immune responses 3 months after booster vaccination

B. Autran, Y. Yazdanpanah, A. Dendooven, 2022, Clinical Microbiology and Infection.

A monoclonal antibody stands out against omicron subvariants: a call to action for a wider access to bebtelovimab

B. Autran, Y. Yazdanpanah, A. Calmy, 2022, The Lancet Infectious Diseases.

Profound and possibly primary "idiopathic CD4+ T lymphocytopenia" in a patient with fungal infections.

D. Olive, É. Oksenhendler, B. Autran, 1994, Clinical immunology and immunopathology.

HIV infection of choriocarcinoma cell lines derived from human placenta: the role of membrane CD4 and Fc-Rs into HIV entry.

B. Autran, F. Barré-Sinoussi, G. Chaouat, 1995, Virology.

Therapeutic immunization with a human immunodeficiency virus (HIV) type 1-recombinant canarypox vaccine in chronically HIV-infected patients: The Vacciter Study (ANRS 094).

V. Calvez, G. Carcelain, R. Tubiana, 2005, Vaccine.

Dynamics in HIV‐DNA levels over time in HIV controllers

B. Autran, C. Rouzioux, L. Meyer, 2019, Journal of the International AIDS Society.

LYMPHADENOPATHY SYNDROME AND SEROCONVERSION TWO MONTHS AFTER SINGLE USE OF NEEDLE SHARED WITH AN AIDS PATIENT

B. Autran, J. Chermann, D. Vittecoq, 1986, The Lancet.

Distinct antibody profiles in HLA-B∗57+, HLA-B∗57− HIV controllers and chronic progressors

N. Paul, B. Autran, O. Lambotte, 2021, AIDS.

Interleukin-2 accelerates CD4 cell reconstitution in HIV-infected patients with severe immunosuppression despite highly active antiretroviral therapy: the ILSTIM study – ANRS 082

V. Calvez, G. Carcelain, R. Tubiana, 2002, AIDS.

Therapeutic vaccines against HIV need international partnerships

B. Walker, C. Katlama, B. Autran, 2003, Nature Reviews Immunology.

Interferon beta transduction of peripheral blood lymphocytes from HIV-infected donors increases Th1-type cytokine production and improves the proliferative response to recall antigens.

B. Autran, P. Debré, W. Rozenbaum, 1997, Proceedings of the National Academy of Sciences of the United States of America.

The HIV infection and immune activation: ‘To fight and burn’

B. Autran, V. Appay, F. Boutboul, 2005, Current infectious disease reports.

Differential Impact of Age and Cytomegalovirus Infection on the γδ T Cell Compartment

Marc Stern, Martin Larsen, Brigitte Autran, 2013, The Journal of Immunology.

Clinical course of cardiomyopathy in HIV-infected patients with or without encephalopathy related to the myocardial expression of tumour necrosis factor-alpha and nitric oxide synthase.

J. Phair, B. Autran, J. Levy, 2000, AIDS.

HIV-1 Reservoir Dynamics after Vaccination and Antiretroviral Therapy Interruption Are Associated with Dendritic Cell Vaccine-Induced T Cell Responses

B. Clotet, B. Autran, Felipe García, 2015, Journal of Virology.

Clinical and laboratory findings of acute Zika virus infection in patients from Salvador during the first Brazilian epidemic

B. Autran, H. Yssel, V. Vieillard, 2020, The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases.

Re-occurrence of HIV-1 drug mutations after treatment re-initiation following interruption in patients with multiple treatment failure.

M. Mouroux, V. Calvez, G. Carcelain, 2001, AIDS.

Persistent low viral load on antiretroviral therapy is associated with T cell-mediated control of HIV replication

V. Calvez, A. Samri, C. Katlama, 2005, AIDS.

Lack of TGF-β production by hepatitis C virus-specific T cells during HCV acute phase is associated with HCV clearance in HIV coinfection.

A. Samri, B. Autran, M. Guiguet, 2012, Journal of hepatology.

Transfer of Human CD 4 1 T Lymphocytes Producing Beta Interferon in Hu-PBL-SCID Mice Controls Human Immunodeficiency Virus Infection

B. Autran, P. Debré, V. Vieillard, 1999 .

A role for cytomegalovirus-specific CD4+CX3CR1+ T cells and cytomegalovirus-induced T-cell immunopathology in HIV-associated atherosclerosis

Jeffrey N. Martin, B. Autran, J. McCune, 2012, AIDS.

[Antiretroviral therapy and immune reconstitution].

V. Calvez, G. Carcelain, R. Tubiana, 1999, Journal de la Societe de biologie.

Structural constraints of HIV-1 Nef may curtail escape from HLA-B7-restricted CTL recognition.

B. Autran, A. Meyerhans, R. Maier, 1997, Immunology letters.

Comprehensive analysis of virus-specific T-cells provides clues for the failure of therapeutic immunization with ALVAC-HIV vaccine

M. Altfeld, B. Clotet, C. Katlama, 2011, AIDS.

Plasticity of lymphoid compartments during HIV infection and treatments: hopes and limits.

G. Carcelain, B. Autran, P. Debré, 2002, Microbes and infection.

Antiretroviral therapy initiation during primary HIV infection enhances both CD127 expression and the proliferative capacity of HIV-specific CD8+ T cells

B. Autran, L. Meyer, O. Lambotte, 2009, AIDS.

Correlation between blood telomere length and CD4+ CD8+ T-cell subsets changes 96 weeks after initiation of antiretroviral therapy in HIV-1–positive individuals

A. Samri, B. Autran, J. Blanco, 2020, PloS one.

Immune reconstitution in HIV infection

B. Autran, 2004 .

Bridging the Gaps between Fundamental, Preclinical and Clinical Research: Report from a Global HIV Vaccine Enterprise Working Group

B. Autran, L. Picker, L. Corey, 2010 .

Human immunodeficiency virus-1 glycoproteins gp120 and gp160 specifically inhibit the CD3/T cell-antigen receptor phosphoinositide transduction pathway.

B. Autran, P. Debré, G. Bismuth, 1990, The Journal of clinical investigation.

HIV-specific cytotoxic T lymphocytes directed against alveolar macrophages in HIV-infected patients.

B. Autran, P. Debré, F. Plata, 1990, Research in virology.

Therapeutic immunization in HIV infection

C. Katlama, B. Autran, S. Kinloch-de Loes, 2006, Current opinion in HIV and AIDS.

Proliferative, IFNγ and IL-2-producing T-cell responses to HIV-2 in untreated HIV-2 infection

F. Brun-Vézinet, G. Carcelain, B. Autran, 2006, AIDS.

Neutralizing Antibodies Against a Specific Human Immunodeficiency Virus gp41 Epitope are Associated With Long-term Non-progressor Status

A. Samri, B. Autran, P. Debré, 2017, EBioMedicine.

Characteristics of the env Genes of HIV Type 1 Quasispecies in Long-Term Nonprogressors With Broadly Neutralizing Antibodies

H. Agut, B. Autran, C. Rouzioux, 2008, Journal of acquired immune deficiency syndromes.

Antibodies to conserved epitopes of the HIV-1 envelope in sera from long-term non-progressors: prevalence and association with neutralizing activity

H. Katinger, H. Agut, B. Autran, 2006, AIDS.

A 5-year neutralizing immune response to yellow fever vaccine in HIV-infected and HIV-uninfected adults

A. Samri, B. Autran, O. Launay, 2022, AIDS.

Bioterrorism: management of major biological agents.

B. Autran, P. Bossi, F. Bricaire, 2006, Cellular and molecular life sciences : CMLS.

HCV drives increased type I IFN-associated impairments associated to fibrosis severity in ART-treated HIV-1-HCV coinfected individuals.

M. Altfeld, C. Katlama, B. Autran, 2017, AIDS (London).

[Evaluation of residual immune response against human pox virus before and after revaccination in healthy volunteers].

B. Autran, E. Rouleau, B. Lebrun-Vignes, 2006, Bulletin de l'Academie nationale de medecine.

Status of long-term asymptomatic HIV-1 infection correlates with viral load but not with virus replication properties and cell tropism. French ALT Study Group.

H. Agut, B. Autran, C. Rouzioux, 1999 .

Extremely severe CD4 lymphopenia during HIV-1 primary infection.

C. Charpentier, B. Autran, P. Ritvo, 2019, AIDS research and human retroviruses.

Low titers of serum antibodies inhibiting hemagglutination predict fatal fulminant influenza A(H1N1) 2009 infection.

G. Carcelain, H. Agut, B. Autran, 2014, American journal of respiratory and critical care medicine.

human immunodeficiency virus infection CD4+CD7-CD57+ T cells: a new T-lymphocyte subset expanded during

C. Katlama, B. Autran, P. Debré, 2011 .

Polyfunctional HIV-specific T cells in Post-Treatment Controllers.

A. Samri, B. Autran, C. Rouzioux, 2016, AIDS.

Low to undetectable Omicron BQ.1.1 neutralization by patient’s sera a month after initiation of AZD7442 600mg

B. Autran, Y. Yazdanpanah, J. Gottenberg, 2023, Journal of Infection.

OPINION Immune control of HIV-1 reservoirs

Brigitte Autran, Benjamin Descours, Charline Bacchus, 2013 .

T-cell and serological responses to Erp, an exported Mycobacterium tuberculosis protein, in tuberculosis patients and healthy individuals

G. Carcelain, B. Autran, T. Ottenhoff, 2007, BMC infectious diseases.

Detection of apoptosis at the single-cell level by direct incorporation of fluorescein-dUTP in DNA strand breaks.

B. Piqueras, B. Autran, P. Debré, 1996, BioTechniques.

Cynomolgus macaque IL37 polymorphism and control of SIV infection

T. Shiina, B. Autran, N. Tchitchek, 2019, Scientific Reports.

Comparable humoral response after two doses of adjuvanted influenza A/H1N1pdm2009 vaccine or natural infection in allogeneic stem cell transplant recipients

B. Autran, A. Thiébaut, J. Bay, 2013, Vaccine.

T-cell-mediated cytotoxicity against HIV in seropositive patients: a physiopathological approach.

B. Autran, P. Debré, M. Denis, 1989, Research in Immunology.

Risk of HIV transmission during combined ART initiation for HIV-infected persons with severe immunosuppression

R. Breban, A. Samri, C. Katlama, 2017, The Journal of antimicrobial chemotherapy.

Restoration of anti‐tetanus toxoid responses in patients initiating highly active antiretroviral therapy with or without a boost immunization: an INITIO substudy

A. Samri, B. Autran, G. Pantaleo, 2008, Clinical and experimental immunology.

Cannabis Use and Plasma Human Immunodeficiency Virus (HIV) RNA Levels in Patients Coinfected With HIV and Hepatitis C Virus Receiving Antiretroviral Therapy: Data From the ANRS CO13 HEPAVIH Cohort

M. Ziol, C. Delaugerre, C. Katlama, 2020 .

[Decrease of erythrocyte receptors for the C3b fragment of complement in acquired immunodeficiency syndrome].

J. Banchereau, B. Autran, P. Debré, 1988, Presse medicale.

Lymphocytic alveolitis after primary HIV infection with CMV coinfection.

B. Autran, L. Couderc, I. Caubarrere, 1997, Chest.

HIV therapeutic vaccine enhances non-exhausted CD4+ T cells in a randomised phase 2 trial

R. Tubiana, C. Katlama, B. Autran, 2019, npj Vaccines.

Arthralgias and cryoglobulinemia during protease inhibitor therapy in a patient infected with human immunodeficiency virus and hepatitis C virus.

B. Autran, L. Musset, D. Vittecoq, 1998, Arthritis and rheumatism.

Tackling latency as a barrier to an HIV cure: what next?

C. Katlama, B. Autran, D. Costagliola, 2015, The lancet. HIV.

Decreased peripheral circulation of HIV-infected cells in a subset of long-term nonprogressors. The French ALT Study Group.

V. Calvez, H. Agut, B. Autran, 1999, Journal of acquired immune deficiency syndromes.

Strong CD4 Th1 responses to HIV and hepatitis C virus in HIV-infected long-term non-progressors co-infected with hepatitis C virus

B. Autran, V. Thibault, V. Di Martino, 2002, AIDS.

HIV-1-Specific Antibody Response and Function after DNA Prime and Recombinant Adenovirus 5 Boost HIV Vaccine in HIV-Infected Subjects

C. Katlama, B. Autran, R. Koup, 2016, PloS one.

Characterization of human immunodeficiency virus type 1 vif gene in long-term asymptomatic individuals.

H. Agut, B. Autran, I. Agostini, 2000, Virology.

The Quest Trial, a paradigm of HIV collaborative research

B. Autran, L. Perrin, D. Cooper, 2000, Nature Medicine.

Host Defenses against Viral Infection

Brigitte Autran, Michael M. Lederman, M. Lederman, 2002 .

Depressive symptoms after hepatitis C cure and socio-behavioral correlates in aging people living with HIV (ANRS CO13 HEPAVIH)

M. Ziol, C. Delaugerre, C. Katlama, 2022, JHEP reports : innovation in hepatology.

Persistent COVID-19 in an immunocompromised host treated by SARS-CoV-2-specific monoclonal antibodies

J. Casanova, S. Imbeaud, B. Autran, 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Increased lung epithelial permeability in HIV-infected patients with isolated cytotoxic T-lymphocytic alveolitis.

B. Autran, P. Debré, M. Denis, 1990, American Review of Respiratory Disease.

HIV therapeutic vaccine enhances non-exhausted CD4+ T cells in a randomised phase 2 trial

R. Tubiana, C. Katlama, B. Autran, 2019, npj Vaccines.

[Biological follow-up of patients with HIV treated with anti-PD-1 or anti-PD-L1 for non-small cell bronchial carcinoma: A task group proposal].

B. Autran, J. Spano, O. Lambotte, 2016, Revue des maladies respiratoires.

A comparison of cell activation, exhaustion and expression of HIV co-receptors and restriction factors in HIV-1 and HIV-2 infected Non Progressors.

C. Charpentier, A. Samri, B. Autran, 2020, AIDS Research and Human Retroviruses.

EFFECT OF TRICYCLIC ANTIDEPRESSANTS ON LYSOSOMAL SPHINGOMYELINASE ACTIVITY

J. Hauw, N. Baumann, B. Autran, 1988 .

Toward a cure for HIV—Seeking effective therapeutic vaccine strategies

B. Autran, 2015, European journal of immunology.

HIV disease progression despite suppression of viral replication is associated with exhaustion of lymphopoiesis.

G. Carcelain, C. Katlama, B. Autran, 2011, Blood.

Characterization of pandemic influenza immune memory signature after vaccination or infection.

A. Samri, B. Autran, F. Carrat, 2014, The Journal of clinical investigation.

Immune and virological benefits of 10 years of permanent viral control with antiretroviral therapy

V. Calvez, G. Carcelain, R. Tubiana, 2010, AIDS.

25 Years of AIDS: recording progress and future challenges.

J. Phair, B. Autran, J. Levy, 2012, AIDS.

Splenic interdigitating dendritic cells in humans: characterization and HIV infection frequency in vivo.

É. Oksenhendler, B. Autran, P. Debré, 1995, Advances in experimental medicine and biology.

A Novel Mode of Human Immunodeficiency Virus Type 1 (HIV-1) Activation: Ligation of CD28 Alone Induces HIV-1 Replication in Naturally Infected Lymphocytes

B. Autran, P. Debré, Y. Dudoit, 1993, Journal of Virology.

Distinct Time Effects of Vaccination on Long-Term Proliferative and IFN-γ–producing T Cell Memory to Smallpox in Humans

G. Carcelain, A. Samri, B. Autran, 2004, The Journal of experimental medicine.

Factors influencing the efficacy of two injections of a pandemic 2009 influenza A (H1N1) nonadjuvanted vaccine in systemic lupus erythematosus.

B. Autran, J. Piette, L. Arnaud, 2011, Arthritis and rheumatism.

Is lymphocyte transfer a promising therapeutic approach towards AIDS?

D. Dormont, B. Autran, W. Rozenbaum, 1987, Annales de l'Institut Pasteur. Immunology.

Repertoire, diversity, and differentiation of specific CD8 T cells are associated with immune protection against human cytomegalovirus disease

G. Carcelain, C. Katlama, B. Autran, 2005, The Journal of experimental medicine.

Epidermodysplasia verruciformis‐like eruption complicating human immunodeficiency virus infection

B. Autran, H. Bachelez, G. Gorochov, 1998, The British journal of dermatology.

Good response to lopinavir/ritonavir-containing antiretroviral regimens in antiretroviral-naive HIV-2-infected patients

B. Autran, J. Ananworanich, K. Ruxrungtham, 2009, AIDS.

CMV driven CD8(+) T-cell activation is associated with acute rejection in lung transplantation.

B. Autran, V. Appay, D. Douek, 2013, Clinical immunology.

Strategies toward restoration of immunity to HIV.

B. Autran, 2002, AIDS.